NCT05392062

Brief Summary

The pathophysiology of SARS-COV-2 related respiratory disease is still poorly understood, especially in its most severe form called acute respiratory distress syndrome (ARDS). In this case, very few studies have investigated changes in gas exchange during COVID-19 progression in spontaneously breathing patients. The investigators purpose in this study to explore the pathophysiology of gas exchange and time course changes in spontaneously breathing patients with acute respiratory failure due to COVID-19. Moreover, our aim is to identify early markers associated with worsening respiratory failure and requiring endotracheal intubation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 9, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 9, 2021

Completed
10 months until next milestone

First Posted

Study publicly available on registry

May 26, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2023

Completed
Last Updated

December 13, 2024

Status Verified

December 1, 2024

Enrollment Period

1.6 years

First QC Date

August 9, 2021

Last Update Submit

December 11, 2024

Conditions

Keywords

Gas exchangeCOVID-19acute respiratory distress syndromespontaneous breathingRespiratory failure

Outcome Measures

Primary Outcomes (1)

  • Association between measurement of intrapulmonary right-to-left shunt, ventilatory ratio and need to intubation.

    From date of admission in intensive care unit (ICU) until the date of death or disharge from ICU, assessed up to 90 days

    Lenght of hospital stay in intensive care unit

Secondary Outcomes (3)

  • Association between measurement of intrapulmonary right-to-left shunt, ventilatory ratio and mortality at D90.

    Day 90

  • Association between measurement of intrapulmonary right-to-left shunt, ventilatory ratio and mortality at D28.

    Day 28

  • Association between intrapulmonary right-to-left shunt, ventilatory ratio with percentage of lung damage on chest CT-scan.

    At admission

Study Arms (1)

Respiratory insufficiency

OTHER

Subject with respiratory insufficiency

Other: Pathophysiology of gas exchange

Interventions

Exploration of pathophysiology of gas exchange

Respiratory insufficiency

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a COVID-19 confirmed infection.
  • Admission in intensive care unit for an acute respiratory failure requiring oxygen flow above 6l/min by facial mask.
  • Presence of an arterial catheter for blood sampling.

You may not qualify if:

  • Patients on mechanical ventilation on admission to the ICU.
  • Patients requiring immediate intubation on admission.
  • Pulmonary embolism diagnosed before admission to the ICU.
  • Minor patients
  • Pregnant women
  • Patients under curatorship or guardianship
  • Persons deprived of liberty by a judicial or administrative decision

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Damien JOLLY

Reims, France

Location

MeSH Terms

Conditions

Respiratory InsufficiencyCOVID-19Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 9, 2021

First Posted

May 26, 2022

Study Start

June 9, 2021

Primary Completion

January 15, 2023

Study Completion

April 15, 2023

Last Updated

December 13, 2024

Record last verified: 2024-12

Locations